Truist Securities cut the price target for Chevron Corporation (NYSE: CVX) from $193 to $190. Truist Securities analyst Neal Dingmann maintained a Hold rating. Chevron shares fell 1.2% to $166.54 in pre-market trading.
Gainers
Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.